|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.94 USD | -9.06% |
|
-7.37% | -13.47% |
BioMarin Pharmaceutical Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 596.42 million compared to USD 519.36 million a year ago. Net income was USD 50.85 million compared to USD 120.8 million a year ago.
Basic earnings per share from continuing operations was USD 0.27 compared to USD 0.66 a year ago. Diluted earnings per share from continuing operations was USD 0.27 compared to USD 0.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.47% | 17.31B | |
| -2.86% | 87.31B | |
| +2.63% | 40.86B | |
| -21.75% | 29.36B | |
| +58.56% | 24.49B | |
| -18.50% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B | |
| -9.82% | 7.9B |
BIOMARIN PHARMACEUTICAL INC. 
